13063_2015_1100_MOESM1_ESM.doc (53 kB)
Download file

Additional file 1: Table S1. of The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry

Download (53 kB)
journal contribution
posted on 19.12.2015, 05:00 by Peter Bramlage, Roland Schmieder, Anselm Gitt, Peter Baumgart, Felix Mahfoud, Hartmut Buhck, Taoufik Ouarrak, Martina Ehmen, Sebastian Potthoff
Patient characteristics for the overall group with those receiving an ACE inhibitor other than ramipril being excluded (n = 151) and split by RCT eligibility at baseline and availability of the 12-month follow-up. (DOC 53 kb)

History